BGNE BeiGene Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: BGNE

Price (delayed)

$316.93

Market cap

$29.23B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.04

Enterprise value

$27.96B

Highlights
The revenue has soared by 179% from the previous quarter and by 114% YoY
The company's gross profit has surged by 133% YoY
BeiGene's debt has soared by 114% YoY and by 14% from the previous quarter
BeiGene's quick ratio has decreased by 42% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.beigene.com/
Peers: ONTX OPK

Key stats

What are the main financial stats of BGNE
Market
Shares outstanding
92.22M
Market cap
$29.23B
Enterprise value
$27.96B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
7.26
Price to sales (P/S)
33.63
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
32.41
Earnings
Revenue
$862.69M
EBIT
-$1.18B
EBITDA
-$1.15B
Free cash flow
-$954.79M
Per share
EPS
-$1.04
Free cash flow per share
-$10.43
Book value per share
$43.66
Revenue per share
$9.42
TBVPS
$63.53
Balance sheet
Total assets
$5.82B
Total liabilities
$1.82B
Debt
$638.62M
Equity
$4B
Working capital
$4.03B
Liquidity
Debt to equity
0.16
Current ratio
4.62
Quick ratio
4.4
Net debt/EBITDA
1.1
Margins
EBITDA margin
-133.1%
Gross margin
89.7%
Net margin
-135.2%
Operating margin
-140.7%
Efficiency
Return on assets
-22.3%
Return on equity
-31.8%
Return on invested capital
-35.8%
Return on capital employed
-25.1%
Return on sales
-137%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BGNE stock price

How has the BeiGene stock price performed over time
Intraday
-1.49%
1 week
-2.78%
1 month
-7.39%
1 year
35.99%
YTD
22.66%
QTD
-7.65%

Financial performance

How have BeiGene's revenue and profit performed over time
Revenue
$862.69M
Gross profit
$773.49M
Operating income
-$1.21B
Net income
-$1.17B
Gross margin
89.7%
Net margin
-135.2%
The revenue has soared by 179% from the previous quarter and by 114% YoY
The company's gross profit has surged by 133% YoY
BGNE's operating margin has surged by 74% since the previous quarter and by 51% year-on-year
BeiGene's net margin has soared by 74% from the previous quarter and by 52% YoY

Growth

What is BeiGene's growth rate over time

Valuation

What is BeiGene stock price valuation
P/E
N/A
P/B
7.26
P/S
33.63
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
32.41
The company's EPS rose by 29% QoQ and by 24% YoY
The equity has grown by 42% YoY and by 3.5% from the previous quarter
The price to book (P/B) is 25% higher than the 5-year quarterly average of 5.8 and 12% higher than the last 4 quarters average of 6.5
The revenue has soared by 179% from the previous quarter and by 114% YoY
BGNE's price to sales (P/S) is 89% lower than its 5-year quarterly average of 296.7 and 50% lower than its last 4 quarters average of 66.9

Efficiency

How efficient is BeiGene business performance
The company's return on sales has surged by 74% QoQ and by 52% YoY
BeiGene's ROIC has soared by 60% YoY and by 35% from the previous quarter
BGNE's return on equity has surged by 54% year-on-year and by 33% since the previous quarter
The company's return on assets has surged by 53% YoY and by 33% QoQ

Dividends

What is BGNE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BGNE.

Financial health

How did BeiGene financials performed over time
BGNE's total liabilities is up by 47% year-on-year and by 5% since the previous quarter
The total assets has increased by 43% year-on-year and by 3.9% since the previous quarter
BeiGene's debt is 84% less than its equity
BeiGene's debt has soared by 114% YoY and by 14% from the previous quarter
BeiGene's debt to equity has increased by 45% YoY and by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.